Purchase this article with an account.
Dongli Yang, Susan G. Elner, Xun Chen, Matthew G. Field, Howard R. Petty, Victor M. Elner; MCP-1–Activated Monocytes Induce Apoptosis in Human Retinal Pigment Epithelium. Invest. Ophthalmol. Vis. Sci. 2011;52(8):6026-6034. doi: 10.1167/iovs.10-7023.
Download citation file:
© 2015 Association for Research in Vision and Ophthalmology.
The inflammatory response in age-related macular degeneration (AMD) is characterized by mononuclear leukocyte infiltration of the outer blood–retina barrier formed by the retinal pigment epithelium (RPE). A key mechanistic element in AMD progression is RPE dysfunction and apoptotic cell loss. The purpose of this study was to evaluate whether monocyte chemoattractant protein (MCP)-1–activated monocytes induce human RPE apoptosis and whether Ca2+ and reactive oxygen species (ROS) are involved in this process.
A cell-based fluorometric assay was used to measure intracellular Ca2+ concentrations ([Ca2+]i) in RPE cells loaded with fluorescent Ca2+ indicator. Intracellular RPE ROS levels were measured by using the 5- and 6-chloromethyl-2′,7′-dichlorodihydrofluorescence diacetate acetyl ester (CM-H2DCFDA) assay. RPE apoptosis was evaluated by activated caspase-3, Hoechst staining, and apoptosis ELISA.
MCP-1–activated human monocytes increased [Ca2+]i, ROS levels, and apoptosis in RPE cells, all of which were inhibited by 8-bromo-cyclic adenosine diphosphoribosyl ribose (8-Br-cADPR), an antagonist of cADPR. Although the ROS scavengers pyrrolidinedithiocarbamate (PDTC) and N-acetylcysteine (NAC) significantly inhibited ROS production and apoptosis induced by activated monocytes, they did not affect induced Ca2+ levels. The induced Ca2+ levels and apoptosis in RPE cells were inhibited by an antibody against cluster of differentiation antigen 14 (CD14), an adhesion molecule expressed by these cells.
These results indicate that CD14, Ca2+, and ROS are involved in activated monocyte-induced RPE apoptosis and that cADPR contributes to these changes. Understanding the complex interactions among CD14, cADPR, Ca2+, and ROS may provide new insights and treatments of retinal diseases, including AMD.
This PDF is available to Subscribers Only